Lupin is currently trading at Rs. 772.00, up by 6.75 points or 0.88% from its previous closing of Rs. 765.25 on the BSE.
The scrip opened at Rs. 772.55 and has touched a high and low of Rs. 773.50 and Rs. 762.70 respectively. So far 46675 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1267.50 on 02-Jun-2021 and a 52 week low of Rs. 678.65 on 07-Mar-2022.
Last one week high and low of the scrip stood at Rs. 773.50 and Rs. 736.35 respectively. The current market cap of the company is Rs. 34955.95 crore.
The promoters holding in the company stood at 46.81%, while Institutions and Non-Institutions held 40.39% and 12.79% respectively.
Lupin has signed definitive agreement with Anglo-French Drugs & Industries for acquiring a portfolio of brands (including all rights and interests associated with such products), to strengthen the Company’s presence in Vitamins, Minerals & Supplements and CNS segments.
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1849.05 |
Dr. Reddys Lab | 1274.25 |
Cipla | 1553.20 |
Lupin | 2184.00 |
Zydus Lifesciences | 1001.85 |
View more.. |